Somatic transgene immunization and related methods
OwnerMaurizio Zanettiinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerMaurizio Zanettiinventor
Estimating the term…
The invention provides a method for stimulating an immune response by administering to a lymphoid cells either in a lymphoid organ or ex vivo, a nucleic acid molecule comprising a hematopoietic cell-specific expression element operationally linked to a nucleic acid sequence encoding one or more heterologous epitopes. The heterologous epitope can be inserted into a complementarity-determining region of an immunoglobulin molecule. The invention also provides a nucleic acid molecule comprising a hematopoietic cell-specific expression element operationally linked to a nucleic acid sequence encoding a heterologous polypeptide. The invention additionally provides a method of treating a condition by administering a nucleic acid molecule comprising a hematopoietic cell-specific expression element operationally linked to a nucleic acid sequence encoding a heterologous polypeptide, wherein the nucleic acid molecule is targeted to a hematopoietic cell.
A method for stimulating an immune response, comprising administering ex vivo to a lymphoid cell a nucleic acid molecule comprising a hematopoietic cell-specific expression element operationally linked to a nucleic acid sequence encoding one or more heterologous epitopes.
2-50. (canceled)
Dependencies are inferred from the claim text.